Editorials Stuart

A.

Groskin,

MD

Emphysema: or Just a Lot To

learn

how

must learn diagnosis scheme Charcot]

we we

do

we

name

W. Smith]

(1)

physema

ous

(2-5).

Much

confusion

of

emphysema

the

arises

from

as clinias emvery

pervades

obvi-

discussions three

corn-

The first misconception originates from the definition of emphysema. Although emphysema is considered part of the spectrum of chronic obstructive pulmonary diseases, expiratory air-flow obstruction is not rnon

misconceptions.

invariably

present

physema.

Expiratory

in

patients

with

em-

air-flow obstruction is neither mentioned in the definition of emphysema nor is it formally required in the diagnosis of emphysema. Emphysema is a pathologic entity that is defined in strictly morphologic terms as the abnormal, irreversible dilatation of terminal air spaces with or without accompanying destruction of alveolar

Until

walls

(6).

the diagnosis of emall but the pathologist because emphysema is, by definition, an abnormality of lung structure, not function, and is diagnosed on the basis of anatomic alterations instead of physiologic abnormalities or clinical sympphysema

toms.

recently, eluded

Definitions

Index terms: high-resolution pulmonary, Radiology

not

withstanding,

em-

Computed tomography (CT), ‘ Editorials #{149}Emphysema, 60.751 #{149}Lung, CT, 60.1211 1992;

183:319-320

From the Department of Radiology, State University of New York Health Science Center at Syracuse, 750 E Adams St, Syracuse, NY 13210. Received March 3, 1992; accepted March 4. Address reprint requests to the author. RSNA, 1992 See also the article by Gurney et al (pp 457463) in this issue. I

expiratory

disease

process.

As

the word “emphysema” eral pathologic observation; imply

of

that

symptomatic

specific

them.

have engendered much anatomic, physiologic, and radiologic controversy

diagnosed only with clinically

sig-

air-flow

obstruction. The second common misconception about emphysema is that it is a single,

we know

EW entities

cal,

nificant

Martin

the things necessarily

Fiction, Air?’ physema is usually when it is associated

one it. The in the

[Jean

name not

because

[Homer

F

disease,

to recognize best trump

of treatment. (1)

Though know, them

to treat

how is the

Fact, offlot

either

a specific

noted

refers

which air

are spaces

associated only,

dial

above,

to a genit does not

dysfunctional

state or a specific pathogenetic nism. Spencer (6) describes anatomic types of emphysema, with and

mecha12 different five of dilatation

seven

of

of which

are

associated with air-space dilatation and alveolar-wall destruction. Some of these forms of emphysema have a clear-cut genetic basis, while others do not. Some

are clearly

related

to cigarette

while others are not. physema frequently significant disability, not. The

third

physema ratory

air-flow

the

airways both

about

the

etiology

obstruction

cur in patients with neither contraction nor

smoking,

that

emphysema. of smooth

em-

the anatomic patient

of mu-

obstruct

air

flow

in

patients with other types of obstructive airways disease, figure prominently in the pathologic or clinical picture of emphysema, some other mechanism of obstruction must be postulated. It was logical, convenient, and tidy to try to find a way to link alveolar-wall destruction, the constant and required morphologic abnormality that defines emphysema, to the air-flow obstruction seen in patients with emphysema. The loss of elastic recoil of the lung and the concomitant loss of radial traction on the small airways seemed likely to provide this link. The intrinsic tendency of the elastic tissue in the alveolar walls to recoil when stretched is the major motivational force for expiratory air flow. Since the connective tissue of the alveolar walls is directly connected to the axial connective tissue surrounding the small airways, the elastic recoil of the alveolar walls also exerts radial traction on small, compliant

airways,

during expiration, trathoracic pressure compress

Destruction

and

pulling

them

open

when positive inwould otherwise

collapse

of alveolar

them.

walls

of radial

may

oc-

should

Both

of these

losses

could

traction

apparently

play

supporting, not starring, roles in this “mortality” play (2). Once we have corrected our misconceptions about emphysema, we are free to ask three questions: (a) Why doesn’t

of expiSince muscle in

hypersecretion

of which

traction.

and should decrease the rate of expiratory air flow. Unfortunately, attempts to directly correlate the extent of alveolarwall destruction with the severity of expiratory air-flow obstruction in patients with emphysema have, at best, met with incomplete success (7-10). Patients with severe emphysema may have few symptoms and little evidence of expiratory air-flow obstruction, while patients with minimal or moderate grades of emphysema may have significant, disabling pulmonary dysfunction. The loss of elastic recoil and the reduc-

tion

types of emclinically others do

misconception

concerns

cus,

Some produce while

reduce the intrinsic elastic recoil of the lung and should also increase the dynamic compression and obstruction of small airways because of the loss of ra-

tent tion

extent

correlate

of emphysema

precisely

of measurable in that patient,

in a

with

pulmonary

the

ex-

dysfunc-

(b) what noninvabe used to most easily and diagnose emphysema, and

sive test can most reliably (c) is there any reason to diagnose anatomically apparent but clinically asymptomatic emphysema? Although it is convenient and cornfortable to think of emphysema as a distinct, discrete entity, it is now widely

recognized ever, exists

that emphysema rarely, if clinically in a pure form. In-

flammation

and fibrosis of small airways bronchiolitis) are found in most patients with emphysema who have verifiable expiratory air-flow obstruction. The extent of these lesions and the severity of the narrowing of the (respiratory

airways

ter,

but

ity

of

extent

that

still

they

produce

correlate

imperfectly,

air-flow

with

obstruction

the

than

of the emphysematous

bet-

sever-

does

the

changes

(7-9).

We will likely match

between

of emphysema lion computed or diagnosed

never the

achieve

presence

a perfect and

extent

detected on high-resolutomographic (CT) scans in surgical or postmortem

lung specimens and measurements expiratory air-flow obstruction,

in most patients, alveolar-wall tion is not the only morphologic

of because

destrucabnor319

mality producing High-resolution

cannot extent

air-flow obstruction. CT has not and likely

be used to assess the degree and of concomitant narrowing of

small

airways.

Dr. Gurney possible

crepancies cabby

et al (11) propose

explanation

another

for apparent

between

dis-

the radiographi-

determined

extent

of emphysema

and physiologic measurements of expiratory air-flow obstruction. They observed that patients who had emphysematous

changes

lung

zones

expiratory

who

had

lung

zone.

primarily

in the

upper

usually had more normal air flow than did patients changes primarily in the lower Dr. Gurney

et al speculate

that because less ventilation normally takes place in the upper lung zones than in the lower lung zones, obstruction

of the

zone

airways

in the

is less likely

ically apparent struction. This cabby attractive

upper

to produce

lung

physiobog-

expiratory air-flow obproposal is physiobogiand benefits from the

generally

accepted

functional

“silent”

precedent zones,

of other where

sub-

stantiab pathologic abnormalities can exist without producing commensurate clinical or physiologic abnormalities. Numerous studies have demonstrated the spectacular capability of CT, particularly high-resolution CT, in the diagnosis of emphysema (12-15). High-

resolution

CT can reliably

physema

and

delineate

depict

em-

its extent

and

severity with accuracy and precision that rival those of direct pathologic amination. This capability is hardly prising.

High-resolution

CT is the

exsurubti-

mate noninvasive way to display the fine anatomic detail of the pulmonary parenchyma.

Although

rich anatomic the diagnosis

detail is of little help in of many pulmonary disor-

extraordinarily

dens, it is precisely what is required for diagnosing emphysema, since emphysema is a disease that is defined not by

the presence of a particular abnormal cellular infiltrate or specific biochemical or functional abnormality, but by an alteration of normal pulmonary structune. The marriage of high-resolution CT and emphysema is truly a match made in heaven. Is it worthwhile

nose

emphysema

tients?

I believe

question

to attempt

to diag-

in asymptomatic that

is a qualified

the

answer

“yes.”

pato this

The early

diagnosis of benign, nonprogressive, functionally insignificant forms of emphysema such as paracicatricial emphysema is, for the most part, unimportant.

On the other of progressive,

320

Radiology

#{149}

hand, the early diagnosis potentially debilitating

forms of emphysema such as centnlobubar emphysema associated with cigarette smoking or panacinar emphysema associated with alpha1-antitrypsin deficiency may have a significant clinical impact. Sequential high-resolution CT studies obtained in asymptomatic and symptomatic patients with potentially disabling forms of emphysema may allow us to learn more about the evolution and natural history of emphysema and provide us with a noninvasive means of measuring

disease

activity

and

response

to therapy. Also, although truly effective treatment for emphysema is still in the developmental stages, once such treatment becomes available, early diagnosis will presumably allow the institution of treatment at an earlier stage, before reversal of or compensation for extensive lung damage is necessary. Finally, if one picture is really worth a thousand words, a high-resolution CT image that graphically demonstrates the destruction of an asymptomatic smoker’s own lung tissue may provide an extremely persuasive argument for him or her to stop smoking. In conclusion, although the cellular and biochemical bases of emphysema are now being elucidated, we still do not truly understand many of the most basic

aspects

of this

disorder.

We

New CT task easier

and may allow us to evaluate the dynamic functional changes taking place in the airways and air spaces of these patients. The eminent pathologist Thurbbeck (2)

why

stated,

“It

so much

spent

trying

nary

function

is interesting

time

and

to

with

has been

tests

of pulmo-

lesions

.

.

The complexity are often not

of the properly

relarecog-

rateby predict some morphological sion. This is predictably the most sive fishing expedition since the

for Moby Dick” (2, pp 129-131). We should respond, “Whale Away

the

boats!”

beexpensearch

ho!

U

References 1. 2.

Strauss

MB.

Boston:

Little, Brown,

Familiar

medical

quotations.

1968; 86, 96.

Thurlbeck WM. Chronic air flow obstruction: correlation of structure and function. In: Petty TL, ed. Chronic obstructive pub-

monary disease. 2nd ed. New York: Dekker, 1985; 129-209. 3.

Bates

DV.

Respiratory

function

ease. 3rd ed. Philadelphia: 4.

172-187. Fraser RG,

Pare

Genereaux

GP.

JAP,

Pare

PD,

Diagnosis

Fraser

RS,

of

Saunders,

Marcus EB, Bulst AS, Maclean CJ, Yano K. Twenty-year trends in mortality from chronic obstructive pulmonary disease: the Honolulu Dis 1989;

6.

1989;

of diseases

the chest. 3rd ed. Philadelphia: 1990; 2087-2166. 5.

in dis-

Saunders,

Heart Program. 140:564-568.

Spencer

H.

Oxford:

Pergamon,

Pathology

Am

Rev

Respir

of the lung.

4th ed.

1985.

7. Silvers GW, MaiselJC, Mitchell

8.

9.

10.

RS.

Petty TL, Filley CF. Flow limitation during

forced expiration in excised human lungs. Appl Physiol 1974; 36:737-744. WrightJL, Lawson UM, Pare PD, Kennedy S, Wiggs B, Hogg JC. The detection of small airways disease. Am Rev Respir Dis 1984; 129:989-994. Hogg JC, Pare PD, Wright JL. Airways disease: evolution, pathology, and recognition. Med J Austrab 1985; 142:605-607. West WW, Nagal A, Hodgkin JE, Thurlbeck WM. The National Institutes of Health Intermittent Positive Breathing Trial-Pathobogy Studies. II. The diagnosis of em-

physema.

Am Rev Respir

Dis 1987; 135:

123-129. 11.

12.

Gurney JW, Jones KK, Robbins RA, et al. Regional distribution of emphysema: correlation of high-resolution CT with pulmonary function tests in unselected smokers. Radiology 1992; 183:457-463. Bergin C, Muller N, Nichols DM, et al. The diagnosis of emphysema: a computed

tomographic-pathologic correlation. Rev Respir Dis 1986; 133:541-545. 13.

Hruban RH, Meziane al. High-resolution

phy of inflation-fixed 14.

15.

Am

MA, Zerhouni EA, et computed tomogra-

lungs.

Am Rev Respir

Dis 1987; 138:935-940. Kuwano K, Matsuba K, Ikeda T, et al. The diagnosis of mild emphysema correlation of computed tomography and pathology scores. Am Rev Respir Dis 1990; 141:169178. Sanders C. The radiographic diagnosis of emphysema. Radiol Clin North Am 1991; 29:1019-1030.

ponder

effort

to correlate

.

nized and there are those even now who search for the Holy Grail of a test of pulmonary function that will accu-

cannot

adequately explain the etiology of the air-flow obstruction in patients with emphysema, nor do we understand the factors that determine an individual’s susceptibility to develop emphysema. Why all people who smoke two packages of cigarettes a day don’t develop emphysema remains a mystery. We should not be disappointed in our inability to exactly match the extent of emphysematous changes with the Severity of pulmonary function abnormalities in patients with emphysema; such a match is not possible, since other factors contribute to the physiologic dysfunction seen in these patients. This does not diminish or devalue the information provided with high-resolution CT and should encourage, not discourage, further efforts to document the sequence of morphologic changes in both the alveoli and the airways that charactenize evolving emphysema. techniques may make this

lungs. tionships

in the

May

1992

Emphysema: fact, fiction, or just a lot of hot air.

Editorials Stuart A. Groskin, MD Emphysema: or Just a Lot To learn how must learn diagnosis scheme Charcot] we we do we name W. Smith] (1...
477KB Sizes 0 Downloads 0 Views